|
|
Profile
|
Delegates :
Mak Inoue |
|
Incorporated :
April 22 , 2021 |
Paid in Capital :
3 Million yen |
Employees :
1 人 |
Address :
Chiba-chuou Twin Bil 2-7 CHIBA-LABO, Chuou2-5-1, Chuou-ku CHIBA
〒260-0013
|
TEL/FAX :
/ |
URL：
https://www.infirmacea.com |
Attachment :
|
Mission/Background :
Keywords: gene therapy, plasmid, non-viral, DNA, subcutaneous injection, gBoost, exFat, biotechnology, drug development, fat, helthspan |
|
Technology & Business
|
Discover gBoost, a groundbreaking technology that dramatically enhances gene expression within specific cells. By seamlessly integrating with viral or non-viral gene delivery systems, gBoost offers a powerful solution to overcome key challenges in cell & gene therapy.
・Maximize Efficacy: Significantly improve the effectiveness of AAV-based gene therapies while enhancing safety profiles.
・Optimize Dosing: Reduce therapeutic doses, potentially leading to lower production costs and reduced side effects.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
gBoost
|
Discovery
|
gBoost is a cell-selective gene expression enhancer for either viral or non-viral gene delivery.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|